Related references
Note: Only part of the references are listed.Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050
Sophie Pilleron et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Does type of cancer affect ovarian response in oncofertility patients?
Reda S. Hussein et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2021)
Novel protection and treatment strategies for chemotherapy-associated ovarian damage
Jiaqiang Xiong et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data
Volkan Turan et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging
Volkan Turan et al.
HUMAN REPRODUCTION UPDATE (2020)
Fertility preservation outcomes in women with gliomas: a retrospective case-control study
Taylor Nordan et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis
Johnny S. Younis et al.
HUMAN REPRODUCTION UPDATE (2020)
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nora Pashayan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Testing and interpreting measures of ovarian reserve: a committee opinion
Alan Penzias et al.
FERTILITY AND STERILITY (2020)
Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
Eleonora Porcu et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2020)
Stress, female reproduction and pregnancy
Georgios Valsamakis et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Association of BRCA Mutations and Anti-mullerian Hormone Level in Young Breast Cancer Patients
Kyung-A Son et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Ovarian damage from chemotherapy and current approaches to its protection
N. Spears et al.
HUMAN REPRODUCTION UPDATE (2019)
BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation
Vinay Gunnala et al.
FERTILITY AND STERILITY (2019)
Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
Oranite Goldrat et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
BRCA mutations and reproduction
Hagit Daum et al.
FERTILITY AND STERILITY (2018)
Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls
Christine Decanter et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2018)
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients
M. Lambertini et al.
ANNALS OF ONCOLOGY (2018)
Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age
Anne Z. Steiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Ovarian reserve testing: a user's guide
Reshef Tal et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma
Roberto Paradisi et al.
FERTILITY AND STERILITY (2016)
New insights in the selection and management of cancer patients applicants for ovarian tissue cryopreservation
Roberto Paradisi et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes
Nigel Pereira et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Patients with cancer at the margins of reproductive age had reduced levels of anti-Mullerian hormone compared with patients experiencing infertility
Mashhour Naasan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)
Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies
Jovana Lekovich et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2016)
Corpus luteum as a novel target of weight changes that contribute to impaired female reproductive physiology and function
Satu Kuokkanen et al.
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response
Stamatina Iliodromiti et al.
HUMAN REPRODUCTION UPDATE (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
BRCA1 germline mutations may be associated with reduced ovarian reserve
Erica T. Wang et al.
FERTILITY AND STERILITY (2014)
Decreased serum anti-Mllerian hormone levels in girls with newly diagnosed cancer
W. van Dorp et al.
HUMAN REPRODUCTION (2014)
The physiology and clinical utility of anti-Mllerian hormone in women
Didier Dewailly et al.
HUMAN REPRODUCTION UPDATE (2014)
Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2014)
Response to ovarian stimulation in patients facing gonadotoxic therapy
Lauren N. C. Johnson et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans
Shiny Titus et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma-evaluation by using antimullerian hormone and retrieved oocytes
Barbara Lawrenz et al.
FERTILITY AND STERILITY (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy
Mausumi Das et al.
FERTILITY AND STERILITY (2011)
Ovarian stimulation for fertility preservation in patients with cancer
Rudolpho B. Quintero et al.
FERTILITY AND STERILITY (2010)
Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Weight change and ovarian steroid profiles in young women
Judith Flynn Chapman et al.
FERTILITY AND STERILITY (2009)
Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies
S. Lie Fong et al.
HUMAN REPRODUCTION (2008)
Predictors of ovarian reserve in young women with breast cancer
K. Lutchman Singh et al.
BRITISH JOURNAL OF CANCER (2007)
Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy
Kutluk Oktay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Clinical evaluation of patients with weight loss-related amenorrhea: Neuropeptide Y and luteinizing hormone pulsatility
Blazej Meczekalski et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment
U Rueffer et al.
ANNALS OF ONCOLOGY (2001)
Semen analysis and cryoconservation before treatment in Hodgkin's disease
O Fitoussi et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
